vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $65.9M, roughly 1.4× OneSpan Inc.). OneSpan Inc. runs the higher net margin — 17.5% vs -98.1%, a 115.6% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 4.1%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 4.0%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.

HIVE vs OSPN — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.4× larger
HIVE
$93.1M
$65.9M
OSPN
Growing faster (revenue YoY)
HIVE
HIVE
+214.5% gap
HIVE
218.6%
4.1%
OSPN
Higher net margin
OSPN
OSPN
115.6% more per $
OSPN
17.5%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
4.0%
OSPN

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
HIVE
HIVE
OSPN
OSPN
Revenue
$93.1M
$65.9M
Net Profit
$-91.3M
$11.6M
Gross Margin
-27.1%
73.6%
Operating Margin
22.5%
Net Margin
-98.1%
17.5%
Revenue YoY
218.6%
4.1%
Net Profit YoY
-234.0%
EPS (diluted)
$-0.38
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
OSPN
OSPN
Q1 26
$65.9M
Q4 25
$93.1M
$62.9M
Q3 25
$87.3M
$57.1M
Q2 25
$45.6M
$59.8M
Q1 25
$63.4M
Q4 24
$29.2M
$61.2M
Q3 24
$22.6M
$56.2M
Q2 24
$32.2M
$60.9M
Net Profit
HIVE
HIVE
OSPN
OSPN
Q1 26
$11.6M
Q4 25
$-91.3M
$43.5M
Q3 25
$-15.8M
$6.5M
Q2 25
$35.0M
$8.3M
Q1 25
$14.5M
Q4 24
$68.2M
$28.8M
Q3 24
$80.0K
$8.3M
Q2 24
$-18.3M
$6.6M
Gross Margin
HIVE
HIVE
OSPN
OSPN
Q1 26
73.6%
Q4 25
-27.1%
73.6%
Q3 25
4.7%
73.6%
Q2 25
-13.6%
73.5%
Q1 25
74.3%
Q4 24
-43.7%
74.0%
Q3 24
-66.1%
73.9%
Q2 24
-7.4%
66.2%
Operating Margin
HIVE
HIVE
OSPN
OSPN
Q1 26
22.5%
Q4 25
19.9%
Q3 25
14.4%
Q2 25
17.6%
Q1 25
27.1%
Q4 24
19.3%
Q3 24
20.0%
Q2 24
12.5%
Net Margin
HIVE
HIVE
OSPN
OSPN
Q1 26
17.5%
Q4 25
-98.1%
69.2%
Q3 25
-18.1%
11.4%
Q2 25
76.8%
13.9%
Q1 25
22.9%
Q4 24
233.2%
47.1%
Q3 24
0.4%
14.7%
Q2 24
-56.7%
10.8%
EPS (diluted)
HIVE
HIVE
OSPN
OSPN
Q1 26
$0.39
Q4 25
$-0.38
$1.13
Q3 25
$-0.07
$0.17
Q2 25
$0.18
$0.21
Q1 25
$0.37
Q4 24
$0.52
$0.73
Q3 24
$0.00
$0.21
Q2 24
$-0.17
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
OSPN
OSPN
Cash + ST InvestmentsLiquidity on hand
$49.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$272.0M
Total Assets
$624.0M
$383.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
OSPN
OSPN
Q1 26
$49.8M
Q4 25
$70.5M
Q3 25
$85.6M
Q2 25
$92.9M
Q1 25
$105.2M
Q4 24
$40.5M
$83.2M
Q3 24
$31.7M
$77.5M
Q2 24
$63.8M
Stockholders' Equity
HIVE
HIVE
OSPN
OSPN
Q1 26
$272.0M
Q4 25
$559.3M
$271.8M
Q3 25
$624.6M
$238.3M
Q2 25
$560.5M
$242.5M
Q1 25
$231.1M
Q4 24
$430.9M
$212.5M
Q3 24
$275.5M
$194.6M
Q2 24
$268.6M
$178.6M
Total Assets
HIVE
HIVE
OSPN
OSPN
Q1 26
$383.1M
Q4 25
$624.0M
$397.7M
Q3 25
$693.0M
$343.5M
Q2 25
$628.7M
$357.1M
Q1 25
$333.8M
Q4 24
$478.6M
$338.7M
Q3 24
$334.7M
$289.3M
Q2 24
$286.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
OSPN
OSPN
Operating Cash FlowLast quarter
$46.0M
$28.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
OSPN
OSPN
Q1 26
$28.2M
Q4 25
$46.0M
$12.6M
Q3 25
$-10.6M
$11.3M
Q2 25
$10.2M
$6.2M
Q1 25
$29.4M
Q4 24
$-28.5M
$12.4M
Q3 24
$-2.2M
$14.0M
Q2 24
$-4.4M
$2.3M
Free Cash Flow
HIVE
HIVE
OSPN
OSPN
Q1 26
Q4 25
$9.6M
Q3 25
$8.8M
Q2 25
$4.4M
Q1 25
$27.7M
Q4 24
$-55.5M
$10.5M
Q3 24
$-34.7M
$12.0M
Q2 24
$26.0K
FCF Margin
HIVE
HIVE
OSPN
OSPN
Q1 26
Q4 25
15.3%
Q3 25
15.4%
Q2 25
7.3%
Q1 25
43.8%
Q4 24
-189.9%
17.1%
Q3 24
-153.4%
21.4%
Q2 24
0.0%
Capex Intensity
HIVE
HIVE
OSPN
OSPN
Q1 26
Q4 25
4.7%
Q3 25
4.4%
Q2 25
3.1%
Q1 25
2.6%
Q4 24
92.5%
3.2%
Q3 24
143.9%
3.5%
Q2 24
3.7%
Cash Conversion
HIVE
HIVE
OSPN
OSPN
Q1 26
2.44×
Q4 25
0.29×
Q3 25
1.74×
Q2 25
0.29×
0.75×
Q1 25
2.02×
Q4 24
-0.42×
0.43×
Q3 24
-26.94×
1.69×
Q2 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

OSPN
OSPN

Product and license$35.5M54%
Services and other$30.4M46%

Related Comparisons